InVivoSIM anti-human integrin alpha4beta7 (LPAM-1) (Vedolizumab Biosimilar), Clone: [Vedolizumab], Human, Monoclonal
Artikelnummer:
BXC-SIM0024
| Artikelname: |
InVivoSIM anti-human integrin alpha4beta7 (LPAM-1) (Vedolizumab Biosimilar), Clone: [Vedolizumab], Human, Monoclonal |
| Artikelnummer: |
BXC-SIM0024 |
| Hersteller Artikelnummer: |
SIM0024 |
| Alternativnummer: |
BXC-SIM0024-1MG,BXC-SIM0024-5MG,BXC-SIM0024-25MG,BXC-SIM0024-50MG,BXC-SIM0024-100MG |
| Hersteller: |
Bio X Cell |
| Wirt: |
Human |
| Kategorie: |
Antikörper |
| Immunogen: |
Human integrin alpha4beta7 (LPAM-1) |
| Klonalität: |
Monoclonal |
| Konzentration: |
Lot specific,typically between 4-11 mg/ml |
| Klon-Bezeichnung: |
[Vedolizumab] |
| Molekulargewicht: |
150 kDa |
| Reinheit: |
>95%, Determined by SDS-PAGE |
| Formel: |
PBS, pH 7.0, Contains no stabilizers or preservatives |
| Target-Kategorie: |
Integrin alpha4beta7 |
| Anwendungsbeschreibung: |
Functional assays, ELISA, Western blot, |
![]()
|
SIM0024 |
